Dmitry Balyasny’s Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share FSNB.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding FSNB.WS
RCM
SCM
SIA
ETH
GAM
SBLIC
DCM
SMA
RCM
Dmitry Balyasny's FSNB.WS Position: Q4 2022 in Review
Dmitry Balyasny sold out of Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share (FSNB.WS) in Q4 2022, closing a stake of 33,333 shares — an estimated $2K sold.
Dmitry Balyasny first reported a position in FSNB.WS in Q2 2021 and held it in 6 quarters. The position peaked at $33K in Q2 2021. 15 funds tracked by Wall St. Rank hold FSNB.WS as of Q4 2022.
- Dmitry Balyasny reported no remaining Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
- Dmitry Balyasny sold 33,333 Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share shares in Q4 2022, an estimated $2K.
- Dmitry Balyasny first reported a position in Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share in Q2 2021 and held it in 6 quarters.
- Dmitry Balyasny's Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position peaked at $33K in Q2 2021.
- 15 funds tracked by Wall St. Rank held Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share as of Q4 2022.
Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.